|
METTL6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.92770244211715E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.6744999548356E-09 |
| Normal-vs-Stage2 |
1.794920E-04 |
| Normal-vs-Stage3 |
1.3417045252595E-11 |
| Normal-vs-Stage4 |
1.94639970807486E-10 |
| Stage1-vs-Stage2 |
4.972000E-01 |
| Stage1-vs-Stage3 |
1.149540E-02 |
| Stage1-vs-Stage4 |
1.143750E-02 |
| Stage2-vs-Stage3 |
2.202000E-02 |
| Stage2-vs-Stage4 |
2.347600E-02 |
| Stage3-vs-Stage4 |
9.155800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14129816708441E-11 |
| Normal-vs-AfricanAmerican |
9.502800E-03 |
| Normal-vs-Asian |
1.54256999999047E-05 |
| Caucasian-vs-AfricanAmerican |
2.691400E-01 |
| Caucasian-vs-Asian |
3.954800E-01 |
| AfricanAmerican-vs-Asian |
5.643800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.58500015732E-10 |
| Normal-vs-Female |
1.96189953172166E-10 |
| Male-vs-Female |
3.358200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.15949999496468E-09 |
| Normal-vs-Age(41-60Yrs) |
2.2370999497312E-09 |
| Normal-vs-Age(61-80Yrs) |
1.70410000555066E-08 |
| Normal-vs-Age(81-100Yrs) |
4.193900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.946000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.988800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.970630E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.434800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.848000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.384200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.323000E-03 |
| Classical-VS-Follicular |
5.302400E-01 |
| Classical-VS-Other |
6.474800E-01 |
| Classical-VS-Normal |
9.99220040043269E-10 |
| Tall-VS-Follicular |
2.067700E-02 |
| Tall-VS-Other |
4.618600E-01 |
| Tall-VS-Normal |
3.10580006157579E-10 |
| Follicular-VS-Other |
8.646400E-01 |
| Follicular-VS-Normal |
9.6233000002055E-07 |
| Other-VS-Normal |
1.539650E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66650000466007E-08 |
| Normal-vs-N1 |
7.65620000731104E-09 |
| N0-vs-N1 |
1.125190E-01 |
|
|
